Eastman Chemical Company (EMN)

NYSE: EMN · USD

$66.6

+0.48 (+0.7%)· Recorded snapshot

영어 원본으로 대체KO

번역하는 동안 영어 원본을 표시 중

이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

StockMarketAgent Research · Analyzed 2026-10-15

Our latest published analysis: EMN rated Buy

Eastman Chemical Company's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$70.1 / share

Potential value

$91.3 / share

Upside to FV

+11.4%

from $66.6

Moat

6.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$7.2B
Revenue (ttm)	8.9B
Net income (ttm)	442M
EPS (ttm)	$3.83
Shares out	114.3M
P/E (trailing)	17.4x
P/E (forward)	9.2x
Dividend	$3.36 (5.07%)
Volume	944,015
Beta	1.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.9B
Net income (ttm): 442M
EPS (ttm): $3.83
P/E (trailing): 17.4x
P/E (forward): 9.2x
Market cap: $7.2B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$10.48B	$10.58B	$9.21B	$9.38B	$8.75B	-4.4%
Gross profit	$2.50B	$2.14B	$2.06B	$2.29B	$1.84B	-7.3%
Operating income	$1.27B	$1.16B	$1.10B	$1.29B	$776.0M	-11.7%
Net income	$857.0M	$793.0M	$894.0M	$905.0M	$474.0M	-13.8%
EPS (diluted)	$6.25	$6.35	$7.49	$7.67	$4.10	-10.0%
EBITDA	$1.81B	$1.64B	$1.59B	$1.80B	$1.29B	-8.2%
R&D	$254.0M	$264.0M	$239.0M	$250.0M	$255.0M	+0.1%
SG&A	$795.0M	$726.0M	$727.0M	$736.0M	$658.0M	-4.6%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	보유
ALB	Albemarle Corporation	11.4B	198.9x	1.9x	4.1%	+12.8%	+1.9%	보유
ANET	Arista Networks Inc.	235.7B	59.1x	22.4x	284.8%	+32.0%	+19.7%	매도
APD	Air Products and Chemicals, Inc.	68.3B	—	5.4x	8.9%	+5.2%	+23.1%	보유
AVY	Avery Dennison Corporation	13.7B	19.8x	1.5x	15.1%	+3.3%	+1.6%	보유
BALL	Ball Corporation	16.7B	18.0x	1.2x	8.7%	+2.3%	+28.3%	매수

Base and Bull scenarios

Bull20%

Price target

$91.33

+45.2% from spot

In the upside path, shares reach $91.33 with an estimated probability of 20.0%, offering an implied return of 45.2% from $62.88. This scenario requires global industrial activity to reaccelerate rapidly, lifting volume demand across specialty additives and advanced materials. Simultaneously, the Kingsport circular plastics platform must ramp seamlessly to full nameplate capacity, capturing premium mix pricing from major consumer brands. Disconfirmation would occur if quarterly volume growth stalls or if customer price increases are rolled back under peer competitive pressure by the middle of FY2027.

Global industrial manufacturing demand reaccelerates sharply, driving strong volume recovery across specialty segments.
Kingsport circular renewal facility reaches full nameplate capacity with premium product mix realization.
Formulaic cost pass-through agreements preserve price realization while raw material and energy costs decline.

Base55%

Price target

$70.07

+11.4% from spot

The modal path projects shares achieving $70.07 with an estimated probability of 55.0%, generating an implied return of 11.4% relative to $62.88. For this path to unfold, management must execute on affirmed structural cost savings programs while operational line-out progress at the Kingsport facility enables orderly volume expansion across FY2026 and FY2027. This path would be disconfirmed if operating margins fail to expand above cyclical trough levels or if customer destocking in chemical intermediates persists past the conclusion of FY2026.

Management achieves affirmed net structural operating expense reductions across the organization.
Commercial ramping at Kingsport progresses through mechanical line-out stages toward full utilization.
North American and European industrial end-market demand normalizes without severe recessionary shock.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($70.07). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	1.8%	2.0%	2.3%	2.5%
8.6%	$74.3	$75.4	$76.6	$77.9	$79.3
9.1%	$71.2	$72.1	$73.1	$74.2	$75.4
9.6%	$68.4	$69.2	$70.1	$71.0	$72.0
10.1%	$65.9	$66.6	$67.3	$68.2	$69.0
10.6%	$63.6	$64.2	$64.9	$65.6	$66.3

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E9.2

P25 n/aP50 n/aP75 n/a

Trailing P/E16.4

P25 n/aP50 n/aP75 n/a

ROE7.3

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EMN indicators

Market & fundamental data

Available fields

284

Groups with data

Currency

USD

Showing 284 of 284 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000915389
Company name	Eastman Chemical Company
Country	United States
Country code	US
CUSIP number	277432100
Earnings date	2026-10-29
Earnings time	amc
Employees	13,000
Employees change	-1,000
Employees growth	-7.14%
Enterprise value	$12.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1920
Industry	Specialty Chemicals
IPO date	1993-10-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US2774321002
Last 10-K release date	2026-02-13
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2011-10-04
Last stock split type	Forward
Market cap	$7.6B
Market cap category	Mid-Cap
Next earnings date	2026-10-29
Options	Yes
Price	$66.60
Price currency	USD
Sector	Materials
SIC code	2821
Stock price date	2026-10-28
Symbol	EMN
U.S. state	Tennessee
Website	https://www.eastman.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	13.45x
Average P/E ratio (10Y)	15.12x
Average P/E ratio (3Y)	13.83x
Average P/E ratio (5Y)	14.36x
Earnings yield	5.75%
EV/Earnings	27.93x
EV/EBIT	14.19x
EV/EBITDA	8.86x
EV/FCF	22.9x
EV/Sales	1.39x
FCF / EV yield	4.37%
FCF yield	7.12%
Forward EV/Sales	1.32x
Forward P/E	9.98x
Forward P/S	0.81x
Graham number	67.80391
Graham upside	2.38%
Industry forward P/E	19.6x
Industry P/E	43.87x
Lynch fair value	$25.32
Lynch upside	-61.78%
P/B ratio	1.24x
P/E ratio	17.38x
P/FCF ratio	14.05x
P/OCF ratio	7.64x
P/S ratio	0.85x
PEG ratio	0.82x
Price / tangible book value	5.01x
Price/EBITDA ratio	5.44x
Sector forward P/E	15.04x
Sector P/E	22.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.81%
EBITDA margin	15.71%
Effective tax rate	17.66%
FCF margin	6.08%
Gross margin	19.66%
Operating margin	9.81%
Pretax margin	6.07%
Profit margin	4.99%
Profit per employee	$34,000
Profitable quarters	20
Profitable years	22
Revenue per employee	$681,923
ROA	3.55%
ROA (5Y)	5.38%
ROCE	6.91%
ROE	7.33%
ROE (5Y)	13.92%
ROIC	6.57%
ROIC (5Y)	10.36%
Tax / revenue	1.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-46.19%
EPS growth (Q)	32.5%
EPS growth (QoQ)	70.97%
EPS growth 10Y	-4.28%
EPS growth 3Y	-13.27%
EPS growth 5Y	10.38%
EPS growth quarters	1
EPS growth years	0
FCF growth	32.76%
FCF growth (Q)	49.4%
FCF growth 3Y	16.15%
FCF growth 5Y	-13.37%
Gross profit growth	-22.15%
Gross profit growth (Q)	10.28%
Gross profit growth 3Y	-5.14%
Gross profit growth 5Y	-5.54%
Net income growth	-46.88%
Net income growth (Q)	30.71%
Net income growth (QoQ)	71.03%
Net income growth 3Y	-14.53%
Net income growth 5Y	6.61%
Net income growth quarters	1
Net income growth years	0
OCF growth	-1.1%
OCF growth (Q)	-3.86%
OCF growth 10Y	-3.98%
OCF growth 3Y	-4.03%
OCF growth 5Y	-7.83%
Operating income growth	-34.88%
Operating income growth (Q)	14.08%
Operating income growth 3Y	-7.77%
Operating income growth 5Y	-7.04%
Revenue growth	-4.53%
Revenue growth (Q)	9.88%
Revenue growth (QoQ)	15.43%
Revenue growth 10Y	-0.38%
Revenue growth 3Y	-3.35%
Revenue growth 5Y	-1.1%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-452M
Depreciation and amortization	$523M
EBIT	$870M
EBITDA	$1.4B
EPS	$3.83
FCF per share	$4.71
Financing cash flow	$-342M
Free cash flow	$539M
Gross profit	$1.7B
Income taxes	$95M
Investing cash flow	$-387M
Net borrowing	$100M
Net cash flow	$268M
Net income	$442M
Operating income	$870M
Revenue	$8.9B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.31
Book value per share	$53.32
Debt / EBITDA	3.62
Debt / equity	0.89
Debt / FCF	10.14
Goodwill	$3.7B
Interest coverage	3.94
Long-term assets	$11.2B
Long-term liabilities	$6.4B
Net cash (debt)	$-4.8B
Net cash / market cap	-63.04%
Net debt / EBITDA	3.43
Net debt / equity	0.77
Net debt / FCF	8.86
Piotroski F-Score	5
Property, plant and equipment	$5.7B
Shareholders' equity	$6.2B
Tangible book value	$1.5B
Tangible book value per share	$13.22
Total assets	$15.4B
Total cash	$693M
Total debt	$5.5B
Total liabilities	$9.2B
WACC	7.3%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	$4.3B
Current liabilities	$2.8B
Current ratio	1.5
Inventory turnover	3.35
Net working capital	$1.6B
Quick ratio	0.72
Working capital	$1.4B
Working capital turnover	5.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.58%
Dividend growth	1.2%
Dividend growth (10Y)	6.21%
Dividend growth (3Y)	2.07%
Dividend growth (5Y)	4.01%
Dividend growth years	16
Dividend payment date	2026-10-07
Dividend payment years	33
Dividend payout frequency	Quarterly
Dividend per share	$3.36
Dividend yield	5.07%
Ex-dividend date	2026-09-15
FCF payout ratio	71.27%
Last dividend	$0.84
Payout ratio	87.68%
Shareholder yield	6.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-1.72%
10Y return CAGR	3.28%
10Y total return	38.11%
150-day SMA	$70.45
15Y price change	65.07%
15Y return CAGR	6.51%
15Y total return	157.51%
1D price change	0.73%
1M price change	-1.28%
1M total return	-1.28%
1W price change	4.11%
1W total return	4.11%
1Y price change	3.65%
1Y return CAGR	8.84%
1Y total return	8.84%
20-day SMA	$64.00
200-day SMA	$71.01
20Y price change	120.99%
20Y return CAGR	7.25%
20Y total return	305.51%
3M price change	-2.32%
3M total return	-1.08%
3Y price change	-8.91%
3Y return CAGR	1%
3Y total return	3.04%
50-day SMA	$67.15
50-day SMA vs 200-day SMA	50under200
52-week high	$83.47
52-week high date	2026-02-12
52-week low	$56.11
52-week low date	2025-11-20
5Y price change	-37.37%
5Y return CAGR	-5.35%
5Y total return	-24.04%
6M price change	-8.32%
6M total return	-6.11%
All-time high	$130.47
All-time high date	2021-06-01
All-time low	$8.88
All-time low date	2009-03-06
Average true range (ATR)	$1.50
Average volume	1.4M
Beta (1Y)	0.47
Beta (2Y)	1.01
Beta (5Y)	1.08
Change from 52-week high	-20.21%
Change from 52-week low	18.7%
Change from all-time high	-49.33%
Change from all-time low	644.48%
Change from open	0.59%
Day's gap	0.14%
Dollar volume	$62.9M
High price	$66.60
Low price	$65.91
Monthly RSI	41.77
Open price	$66.21
Position in 52-week range	100%
Premarket change	-0.08%
Premarket close	$66.12
Premarket price	$66.07
Premarket volume	473
Previous close	$66.12
Price vs 150-day SMA	-5.47%
Price vs 20-day SMA	4.06%
Price vs 200-day SMA	-6.21%
Price vs 50-day SMA	-0.81%
Relative volume	0.66
RSI	55.51
Sharpe ratio	0.3
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	-0.15
Sortino ratio	0.65
Sortino ratio (3Y)	0.33
Sortino ratio (5Y)	-0.03
Volume	944K
Weekly RSI	45.08
YTD price change	3.57%
YTD total return	7.35%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113.3M
Float percentage	99.07%
Shares change (QoQ)	0.26%
Shares change (YoY)	-1.58%
Shares held by insiders	0.8%
Shares held by institutions	94.63%
Shares outstanding	114.3M
Short % of float	5.89%
Short % of shares	5.83%
Short ratio	5.7 days

Deeper analysis on EMN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this EMN report

What is the latest published EMN stock rating?

Eastman Chemical Company is shown with Buy in the latest published report, analyzed 2026-10-15. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EMN analysis?

The full latest published report, analyzed 2026-10-15, lives at /stocks/EMN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for EMN?

The latest published report analyzed 2026-10-15 gives EMN a fair value of USD 70 and a potential value of USD 91. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the EMN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-10-15). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

BuyEMN · Fair value $70.1+11.4%

Read full analysis →

Eastman Chemical Company (EMN)

Our latest published analysis: EMN rated Buy

Price

Financial snapshot

Fair-value bridge

Latest news · EMN

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All EMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EMN

Frequently asked questions

등급 이력

Category	Score	Reading
Valuation	7.5
Management	6.5
Balance Sheet	5.0
Profitability	5.0
Revenue Growth	6.0
Risk Assessment	6.5
Competitive Moat	6.5
Earnings Quality	9.0
Capital Efficiency	3.5